Ruti Alon, co-chairman of this year’s IATI-Biomed Conference, highlighted that Israeli research is present in between 25% and 28% of the world’s successful biotech-based solutions. E.g. Exelon for Alzheimer’s, Doxil for cancer and Copaxone for Multiple Sclerosis.
http://www.timesofisrael.com/one-in-four-life-science-innovations-has-israeli-roots-says-expert/